すぐに使えるリウマチ・膠原病診療マニュアル　改訂版

出版社： 羊土社
著者：
発行日： 2015-04-10
分野： 臨床医学：内科  >  膠原病/リウマチ
ISBN： 9784758117678
電子書籍版： 2015-04-10 （第2版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

6,050 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

6,050 円(税込)

購入する

商品紹介

リウマチ非専門医にわかりやすい大好評マニュアルの改訂版．リウマチ性疾患の“一発診断”に役立つパールや臨床現場で実用されている診断基準，エビデンスの解説がさらに充実．豊富な写真で膠原病特有の所見がよくわかる！

目次

  • すぐに使えるリウマチ・膠原病診療マニュアル　改訂版

    ―目次―

    第1章　一発診断 目で見るリウマチ
    手指・爪の病変
    関節リウマチと間違われる疾患
    手掌および足底部の病変
    SLEでみられる皮疹とみられない皮疹
    誤診の多い偽痛風
    重大疾患の手がかりとなる病変
    “視診”を忘れるな

    第2章　関節X線ASBCD
    関節X線の読み方の基本と特徴的な所見（手のX線を中心に）

    第3章　基本編 関節痛へのアプローチ
    1.総論 〜詳細な病歴
    2.各論

    第4章　病棟編 不明熱
    1.総論
    2.発熱・関節炎
    3.血管炎
    4.成人スティル病
    5.巨細胞性動脈炎（側頭動脈炎）
    6.不明熱診療における感染症の考え方
    7.まずは除外“悪性疾患”による発熱
    《コラム》自然免疫と自己炎症性疾患

    第5章　外来編
    1.関節リウマチの診療
    2.高齢者のコモンディジーズ 〜リウマチ性多発筋痛症
    《コラム》2014年ACR特発性炎症性筋炎の新分類基準
    《コラム》2014年ACR-EULAR PMR治療ガイドライン
    3.抗核抗体陽性患者のコンサルト
    4.RF陽性患者のコンサルト
    5.こんなにこわいシェーグレン
    《コラム》2012年ACR SICCA シェーグレン症候群分類基準
    6.内分泌疾患に伴う筋骨格系疾患
    7.骨粗鬆症
    《コラム》CKD患者での骨粗鬆症治療
    8.「あちこち痛い！」そんな患者さんが来たら？？
    9.筋痛，筋力低下患者のアプローチ
    10.ガンコな口内炎

    第6章　救急編 急性単関節炎のアプローチ
    1.関節穿刺と関節液分析
    2.感染性関節炎（化膿性関節炎）
    3.偽痛風
    4.痛風

    第7章　リウマチ治療薬
    1.ステロイド
    2.生物学的製剤

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 一発診断 目で見るリウマチ

P.14 掲載の参考文献
Wigley FM : Raynaud's Phenomenon. N Engl J Med, 347 : 1001-1008, 2002
PubMed
Block JA, Sequeria W : Raynaud's phenomenon. Lancet, 357 : 2042-2048, 2001
 
P.18 掲載の参考文献
1) Ohtsuka T et al : Image analysis of nail fold capillaries in patients with Raynaud's phenomenon. Cutis, 56 : 215-218, 1995
PubMed
2) Van den Hoogen F, et al : 2013 classification criteria for systemic sclerosis : an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum, 65 : 2737-2747, 2013
PubMed
3) Walker UA, et al : Clinical risk assessment of organ manifestations in systemic sclerosis : a report from the EULAR Scleroderma Trials and Research Group database. Ann Rheum Dis, 66 : 754-763, 2007
 
Scleroderma from A to Z from the non profit international scleroderma network. Access at http://www.sclero.org/medical/journals/scar/a-to-zhtml
 
P.22 掲載の参考文献
Fawsett RS, et al : Nail abnormalities : clues to systemic disease. Am Fam Physician, 69 : 1417-1424, 2004
 
『手で診るリウマチ』(上野征夫編), 医学書院, 2002
 
P.27 掲載の参考文献
1) Rudwaleit M. "ASAS slides集" EULAR 2010
 
2) Rudwaleit M, et al : The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II) : validation and final selection. Ann Rheum Dis, 68 : 777-783, 2009
PubMed
3) van der Linden S, et al : Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum, 27 : 361-368, 1984
PubMed
4) van der Heijde D, et al : 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis, 70 : 905-908, 2011
PubMed
5) Sieper J, et al : New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the assessment of spondyloarthritis international society (ASAS). Ann Rheum Dis, 68 : 784-788, 2009
PubMed
O'Dell JR. : Therapeutic strategies for rheumatoid arthritis. N Engl J Med, 350 : 2591-2602, 2004
PubMed
Zochling J, et al : Current evidence for the management of ankylosing spondylitis : a systemic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis, 65 : 423-432, 2006
 
P.32 掲載の参考文献
1) Taylor W, et al : Classification criteria for psoriatic arthritis. Arthritis Rheum, 54 : 2665-2673, 2006
PubMed
2) Ritchlin CT, et al : Treatment recommendations for psoriatic arthritis. Ann Rheum Dis, online first : 24 Oct 2008
 
Zhang W, et al : EULAR evidence based recommendations for the management of hand osteoarthritis : report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis, 66 : 377-388, 2007
PubMed
P.36 掲載の参考文献
1) Eshed I, et al : MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis, 66 : 1553-1559, 2007
PubMed
2) Resnick D, et al : Entheses and enthesopathy. Radiology, 146 : 1-9, 1983
PubMed
P.39 掲載の参考文献
1) McCarty DJ, et al : Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA, 254 : 2763-2767, 1985
PubMed
2) Sibilia J, et al : Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) : a form of paraneoplastic polyarthritis. J Rheumatol, 26 : 115-120, 1999
PubMed
P.41 掲載の参考文献
Murphy WA, et al : Jaccoud's arthropathy reviewed. Am J Roentgenol, 118 : 300-307, 1973
 
Palazzi C, et al : Jaccoud's arthropathy of the hands as a complication of pylophosphate arthropathy. Rheumatology, 40 : 354-355, 2001
 
P.44 掲載の参考文献
Hypertrophic Osteoarthropathy. eMedicine [http://www.emedicine.com/radio/topic357.htm]
 
Myers KA, et al : The rational clinical examination. Does this patient have clubbing? JAMA, 286 : 341-347, 2001
PubMed
P.46 掲載の参考文献
1) Palmar erythema in rheumatoid arthritis. Clinical Rheumatology, 4 : 449-451, 1985
PubMed
P.49 掲載の参考文献
DermNet Nz. Acquired keratoderma. Access at http://www.dermnetznz.org/scaly/acquired-keratoderma.html
 
P.53 掲載の参考文献
Cutaneous manifestations of systemic lupus erythematosus. UpToDate ONLINE. Access at http://www.uptodate.com/home/index.html
 
P.57 掲載の参考文献
Cutaneous manifestations of systemic lupus erythematosus. UpToDate ONLINE. Access at http://www.uptodate.com/home/index.html
 
P.62 掲載の参考文献
1) 厚生労働省 岡崎班・梅原班 : IgG4関連疾患包括診断基準 2011. 日内会誌, 101 : 795-804, 2012
 
2) Okazaki K, et al : How to diagnose autoimmune pancreatitis by the revised Japanese clinical. criteria. J Gastroenterol, 42 : 32-38, 2007
PubMed
Koler RA, et al : Dermatomyositis. Am Fam Physician, 64 : 1565-1572. 2001
PubMed
Sontheimer RD : Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol, 46 : 626-636, 2002
PubMed
Kamisawa T, et al : IgG4-related disease. Lancet, 2014 Dec3. pii : S0140-6736 (14) 60720-0. doi : 10. 1016/S0140-6736 (14) 60720-0. [Epub ahead of print]
 
Stone JH, et al : IgG4-related disease. N Engl J Med, 366 : 539-551, 2012
PubMed
Sato Y, et al : Systemic IgG4-related lymphadenopathy : a clinical and pathologic comparison to multicentric castleman's disease. Modern Pathology, 22 : 589-599, 2009
PubMed
P.67 掲載の参考文献
1) Miyakis S, et al : International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost, 4 : 295-306, 2006
 
Gibbs MB, et al : Livedo reticularis : An update. J Am Acad Dermatol, 52 : 1009-1019, 2005
PubMed
P.69 掲載の参考文献
Aouba A, et al : Crowned dens syndrome misdiagnosed as polymyalgia rheumatica, giant cell arteritis, meningitis or spondylitis : an analysis of eight cases. Rheumatology, 43 : 1508-1512, 2004
PubMed
P.73 掲載の参考文献
1) Mizushima Y : Revised diagnostic criteria for Behcet's disease in 1987. Ryumachi, 28 : 66-70, 1988
PubMed
Erythema nodosum, UpToDate. http://www.uptodate.com
 
P.75 掲載の参考文献
Mandel L, et al : Bilateral parotid swelling : A review. Oral Surg Oral Med Oral Radiol Endod, 93 : 221-237, 2002
PubMed
P.77 掲載の参考文献
1) 厚生労働省 岡崎班・梅原班 : IgG4関連疾患包括診断基準 2011. 日内会誌, 101 : 795-804, 2012
 
2) Okazaki K, et al : How to diagnose autoimmune pancreatitis by the revised Japanese clinical. criteria. J Gastroenterol, 42 : 32-38, 2007
PubMed
Kamisawa T, et al : IgG4-related disease. Lancet, 2014 Dec3. pii : S0140-6736 (14) 60720-0. doi : 10.1016/S0140-6736 (14) 60720-0. [Epub ahead of print]
 
Stone JH, et al : IgG4-related disease. N Engl J Med, 366 : 539-551, 2012
PubMed
Sato Y, et al : Systemic IgG4-related lymphadenopathy : a clinical and pathologic comparison to multicentric castleman's disease. Modern Pathology, 22 : 589-599, 2009
PubMed
P.79 掲載の参考文献
青木眞 : 帯状疱疹. レジデントのための感染症診療マニュアル 第2版, 医学書院, pp763-764, 2008
 

第3章 基本編 関節痛へのアプローチ

P.99 掲載の参考文献
1) American College of Rheumatology Ad Hoc Committee on clinical guidelines. : Guidelines for the initial evaluation of the adult patient with acute musculoskeletal symptoms. Arthritis Rheum, 39 : 1-8, 1996
 
Pinals RS. : Polyarthritis and fever. N Engl J Med 310 : 769-774, 1994
 
Helfgott SM, Kratz A. : Case 19 -2001- A 50-Year-Old Man with Fever and Joint pain. N Engl J Med, 344 : 1929-1935, 2001
 
Richie AM, et al : Diagnosis approach to polyarticular joint pain. Am Fam Physician 68 : 1151-1160, 2003
 
P.107 掲載の参考文献
Neck pain : Kelley's Textbook of Rheumatology. 8th Edition. pp571-585, Saunders, Elsevier, 2008
 
P.116 掲載の参考文献
Shoulder pain : Kelley's Textbook of Rheumatology. 8th Edition. pp587-616, Saunders, Elsevier, 2008
 
P.119 掲載の参考文献
Anderson B, et al : Evaluation of the patient with elbow pain. UpToDate, online. http://www.uptodate.com/home/index.html
 
P.124 掲載の参考文献
Hand and Wrist pain : Kelley's Textbook of Rheumatology. 8th Edition. p651-663, Saunders, Elsevier, 2008
 
D'Arcy CA, et al : Does this patient have carpal tunnel syndrome? JAMA, 283 : 3110-3117, 2000
PubMed
Katz JN, et al : Carpal tunnel syndrome. N Engl J Med, 346 : 1807-1812, 2002
PubMed
P.133 掲載の参考文献
1) 林寛之 : 8章 たかが腰痛なんだけど…. Step Beyond Resident 5, 羊土社, pp141-172, 2008
 
2) Sieper J, et al : New criteria for inflammatory back pain in patients with chronic back pain. Ann Rheum Dis, Epub on January 15, 2009
 
Carragee EJ : Persistent low back pain. N Engl J Med, 352 : 1891-1898, 2005
PubMed
Jarvik JG, et al : Diagnostic evaluation of low back pain with emphasis on imaging. Ann Intern Med, 137 : 586-597, 2002
PubMed
P.138 掲載の参考文献
Hip pain : Kelley's Textbook of Rheumatology. 8th ed. pp636-642, Saunders, Elsevier, 2008
 
P.146 掲載の参考文献
Kneepain : Kelley's Textbook of Rheumatology. 8th Edition. p627-636, Saunders, Elsevier, 2008
 
Review : Physical diagnostic tests have low diagnostic accuracy for meniscallesions of the knee. ACP Journal Club May/June 136 : 2002
 
P.151 掲載の参考文献
Foot and Ankle pain : Kelley's Textbook of Rheumatology. 8th ed. pp643-663, Saunders, Elsevier, 2008
 

第4章 病棟編 不明熱

P.159 掲載の参考文献
1) Durack DT, et al : Fever of unknown origin--reexamined and redefined. Curr Clin Top Infect Dis, 11 : 35-51, 1991
PubMed
2) Mourad G, et al : A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med, 163 : 545-551, 2003
 
3) Johnson DH, et al : Drug fever. Infect Dis Clin North Am, 10 : 85-91, 1996
PubMed
4) Cunha BA : Fever of unknown origin : clinical overview of classic and current concepts. Infect Dis Clin north Am, 21 : 867-915, 2007
PubMed
5) Kubota K, et al : FDG-PET for the diagnosis of fever of unknown origin : a Japanese multi-center study. Ann Nucl Med, 25 : 355-364, 2011
PubMed
6) Knockaert DC : Long-term follow-up of patients with undiagnosed fever of unknown origin. Arch Intern Med, 156 : 618-620, 1996
PubMed
7) Mettler FA Jr, et al : Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology, 248 : 254-263, 2008
PubMed
8) Vanderschueren S, et al : Lack of value of the naproxen test in the differential diagnosis of prolonged febrile illnesses. Am J Med, 115 : 572-575, 2003
PubMed
9) Petersdorf RG, et al : Fever of unknown origin. An old friend revisited. Arch Intern Med, 152 (1) : 21-22, 1992
PubMed
10) Mackowiak PA, et al : Concepts of fever : recent advances and lingering dogma. Clin Infect Dis, 25 : 119-138, 1997
PubMed
Fever of unknown origin in adults : 40 years on. J Intern Med, 253 (3) : 263-275, 2003
 
P.165 掲載の参考文献
1) Gary S, et al : "Kelly's Textbook of Rheumatology 9th". Saunders, 2012
 
3) Spinner RJ, et al : Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis. J Arthroplasty, 11 : 217-222, 1996
PubMed
4) Watts HG, et al : Tuberculosis of bones and joints. J Bone Joint Surg Am, 78 : 288-98, 1996
PubMed
5) Quiceno GA, et al : Iatrogenic rheumatic syndromes in the elderly. Rheum Dis Clin North Am, 33 : 123-34, 2007
PubMed
6) Pinals RS, et al : Polyarthritis and fever. N Engl J Med, 330 : 769-774, 1994
PubMed
2） Hodgson SP, et al : Ten-year experience of bone and joint tuberculosis in Blackburn 1978-1987. J R Coll Surg Edinb, 35 : 259-262, 1990
PubMed
Guidelines for the initial evaluation of the adult patient with acute musculoskeletal symptoms. American college of rheumatology ad hoc committee on clinical guidelines. Arthritis Rheum, 39 (1) : 1-8, 1996
 
P.175 掲載の参考文献
1) Jennette JC, et al : 2012 revised International chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum, 65 : 1-11, 2013
 
2) Kelley's Textbook of Rheumatology, 8/e p.1403 Table. 80-2, Elsevier Saunders, 2004
 
3) Mahr A, et al : Brief report : prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheumatol, 66 : 1672-1677, 2014
PubMed
4) Watts R, et al : Development and validation of a consensus methodology for the classification of the ANCAassociated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis, 66 : 222-227, 2007
PubMed
5) Ozen S, et al : EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis : Ankara 2008. Part II : Final classification criteria. Ann Rheum Dis, 69 : 798-806, 2010
PubMed
6) Ntatsaki E, et al : BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford), 53 : 2306-2309, 2014
PubMed
7) Guillevin L, et al : Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore), 75 : 17-28, 1996
PubMed
8) Gayraud M, et al : Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome : analysis of four prospective trials including 278 patients. Arthritis Rheum, 44 : 666-675, 2001
PubMed
9) Guillevin L, et al : The Five-Factor Score revisited : assessment of prognoses of systemic necrotizing vasculitides based on the French vasculitis study group (FVSG) cohort. Medicine, 90 : 19-27, 2011
 
10) de Groot K, et al : Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis : a randomized trial. Ann Intern Med, 150 : 670-680, 2009
PubMed
11) Pagnoux C, et al : Treatment of systemic necrotizing vasculitides in patients over 65 years. Arthritis Rheumatol. 2015 Feb 18. doi : 10.1002/art.39011. [Epub ahead of print]
 
P.181 掲載の参考文献
1) Hochberg MC, Silman AJ, Smolen JS, et al : Rheumatology, 6th ed, Mosby, 2014
 
2) Moore C Jr, et al : Causes and significance of markedly elevated serum ferritin levels in an academic medical center. J Clin Rheumatol, 19 : 324-328, 2013
 
3) Yamaguchi M, et al : Preliminary criteria for classification of adult Still's disease. J Rheumatol, 19 : 424, 1992
 
Efthimiou P, et al : Diagnosis and management of adult onset Still's disease. ann rheum dis, 65 : 564-572, 2006
PubMed
P.188 掲載の参考文献
1) Smetana GW, et al : Does this patient have temporal arteritis? JAMA, 287 : 92, 2002
PubMed
2) Firestein GS, et al : Kelley's textbook of rheumatology. 9th ed. Saunders (Philadelphia), 2012
 
Mukhtyar C, et al : EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis, 68 : 318-323, 2009
PubMed
P.194 掲載の参考文献
1) Li JS, et al : Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis, 30 : 633-638, ,2000
 
2) Shmerling RH : Autoantibodies in systemic lupus erythematosus--there before you know it.N Engl J Med, 349 : 1499-1500, 2003
PubMed
3) Aggarwal R, et al : Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum, 61 : 1472-1483, 2009
PubMed
4) Bosch X, et al : Antineutrophil cytoplasmic antibodies. Lancet, 368 : 404-418, 2006
PubMed
5) Khasnis A, Molloy E : Mimics of primary systemic vasculitides. International Journal of Clinical Rheumatology, 4 (5) : 597-609, 2009
 
6) Csernok E, et al : Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol. 22 : 43-48, 2010
PubMed
7) Muto G et al : A patient with intravascular lymphoma presenting with cerebral infarction and a high serum MPO-ANCA level. Mod Rheumatol, 21 : 207-210, 2011
 
8) Mahr A, et al : Brief report : prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheumatol, 66 : 1672-1677, 2014
PubMed
Cunha BA. : Fever of unknown origin : clinical overview of classic and current concepts. Infect Dis Clin North Am, 21 (4) : 867-915, 2007
PubMed
Mourad O, Palda V, Detsky AS. : A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med, 163 : 545-551, 2003
PubMed
Christopher H, Dominick T. : Diagnostic evaluation of mononucleosis-like illnesses. The American Journal of Medicine, 120 : 911. e1-911. e8, 2007
 
P.201 掲載の参考文献
1) Cunha BA, et al : Fever of unknown origin : focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests. Infect Dis Clin North Am, 21 : 1137-118, 2007
PubMed
2) Racanelli V, et al : Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev, 7 : 352-358, 2008
PubMed
Manger B & Schett G : Paraneoplastic syndromes in rheumatology. Nat Rev Rheumatol, 10 : 662-670, 2014
PubMed
Burke A, et al : Fever of unknown origin : focused diagnostic approach based on clinical clues from the history, physical examlnation, and laboratory tests. Infect Dis Clin N Am, 21 : 1137-1187, 2007
 
Fever of unknown origin : Focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests
 
P.203 掲載の参考文献
1) 井田弘明 : 久留米医学会雑誌, 73 : 312-318, 2010
Medical*Online
平家俊男 : 自己炎症性疾患総論. 分子リウマチ治療, 7 (1) : 1-6, 2014
Medical*Online
Ozen S, et al : A clinical guide to autoinflammatory diseasesl : familial mediterranean fever and next-of-kin. Nat Rev Rheumatol, 10 : 135-147, 2014
 
右田清志, 他 : 家族性地中海熱の臨床. 炎症と免疫, 21 (1) : 40-46, 2013
Medical*Online
Washio M, et all : Tumor necrosis factor receptor-associated periodic syndrome (TRAPs) in japanl : a review of the literature. Mod Rheumatol, 23 (2) l : 210-217, 2013
 

第5章 外来編

P.209 掲載の参考文献
1) 「すぐに使えるリウマチ・膠原病診療マニュアル」山本万希子, p176, 羊土社, 2009
 
2) 「新基準検証委員会報告書」日本リウマチ学会新基準検証委員会, 2011 http://www.ryumachi-jp.com/info/news110913.pdf
 
3) Aggarwal R, et al : Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum, 61 : 1472-1483, 2009
PubMed
4) 「関節のMRI」 (福田邦彦編), メディカル・サイエンス・インターナショナル, 2007
 
Combe B, et al : EULAR recommendations for the management of early arthritis : report of a task force of the European standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis, 66 : 34-45, 2007
PubMed
Singh JA, Furst DE, Bharat A et al : 2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res, 64 (5) : 625-639, 2012
PubMed
Aletaha D, Neogi T, Silman AJ et al : 2010 Rheumatoid arthritis classification criteria : an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum, 62 (9) : 2569-2581, 2010
PubMed
P.215 掲載の参考文献
1) Smolen JS, et al : Treating rheumatoid arthritis to target : recommendations of an international task force. Ann Rheum Dis, 69 : 631-637, 2010
PubMed
2) Felson DT, et al : American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum, 63 : 573-586, 2011
PubMed
P.222 掲載の参考文献
1) Saravanan V, et al : Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology, 43 : 143-147, 2004
PubMed
Harris E, et al : Kelly's Textbook of Rheumatology, WB Saunders Co, Philadelphia, 2004
 
P.232 掲載の参考文献
1) Singh JA, Furst DE, Bharat A, et al : 2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res, : 625-639, 2012
PubMed
2) Smolen JS, Landewe R, Breedveld FC, et al : EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2013 update. Ann Rheum Dis, 69 (6) : 964-975, 2010
 
3) Goekoop-Ruiterman YP, et al : Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the best study) : A randomized, controlled trial. Arthritis Rheum, 52 : 3381-3390, 2005
PubMed
4) 日本リウマチ学会MTX診療ガイドライン策定小委員会編 : 関節リウマチ診療におけるメトトレキサート診療ガイドライン, 羊土社，2011
 
P.238 掲載の参考文献
1) 西岡淳一ほか : リウマチ, 25 : 265, 1985
 
2) Dasgupta B, et al : 2012 Provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism/American college of rheumatology collaborative initiative. Arthritis Rheum, 64 : 943-954, 2012
PubMed
Brooks PC : Diagnostic dilenmmas in polymyalgia rheumatica. Arch Intern Med, 157 : 162-168, 1997
 
Salvarani C, et al : Polymyalgia rheumatica and giant cell arteritis. Lancet, 372 : 234-245, 2008
PubMed
P.246 掲載の参考文献
1) Hochberg MC : Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 40 : 1725, 1997
PubMed
2) Tan EM, et al : The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 25 : 1271-1277, 1982
PubMed
3) Petri M, et al : Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum, 64 : 2677-2686, 2012
PubMed
Moder K : Use and interpretation of rheumatologic tests : a guide for clinicians. Mayo Clin Proc, 71 : 391-396, 1996
PubMed
Wanchu A : Antinuclear antibodies : clinical applications. J Postgrad Med, 46 : 144-148, 2000
PubMed
P.256 掲載の参考文献
1) Hochberg MC, et al : Rheumatology. 6th ed. pp1132-1143. Elsevier Inc., Philadelphia, 2014
 
2) Vitali C, et al : Classification criteria for Sjogren's syndrome : a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis, 61 : 554-558, 2002
 
3) Ramos-Casals M, et al : Treatment of primary Sjogren syndrome ; a systematic review. JAMA, 304 : 452-460, 2010
PubMed
UpToDate http://www.uptodate.com/home/index.html "Clinical manifestations of Sjogren's syndrome : Exocrine gland disease" "Clinical manifestations of Sjogren's syndrome : Extraglandular disease" "Treatment of Sjogren's syndrome"
 
P.257 掲載の参考文献
1) Shiboski SC, et al : American college of rheumatology classification criteria for sjogren's syndrome : a data-driven, expert consensus approach in the sjogren's international collaborative clinical alliance cohort. Arthritis Care Res, 64 : 475-487, 2012
 
P.267 掲載の参考文献
1) 「骨粗鬆症の予防と治療ガイドライン 2011年版」 (骨粗鬆症の予防と治療ガイドライン作成委員会編), 2011
 
2) Center JR, et al : Risk of subsequent fracture after low-trauma fracture in men and women. JAMA, 297 : 387-394, 2007
PubMed
3) 「原発性骨粗鬆症の診断基準 (2012年度改訂版) 」. Osteoporosis Japan, 21 (1) : 9-18, 2013
 
4) Briot K, et al. : Accuracy of patient-reported height loss and risk factors for height loss among postmenopausal women. CMAJ, 182 : 558-562, 2010
PubMed
5) Peris P, et al : Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum, 32 : 64-70, 2002
 
6) Cohen A, et al : Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD : the experience of an osteoporosis referral center. J Womens Health, 18 : 79-84, 2009
 
7) Peris P, et al : Aetiology and presenting symptoms in male osteoporosis. Br J Rheumatol, 34 : 936-941, 1995
PubMed
8) Peris P, et al : Aetiology and clinical characteristics of male osteoporosis. Have they changed in the last few years? Clin Exp Rheumatol, 26 : 582-588, 2008
PubMed
9) Daniell HW : Osteoporosis after orchiectomy for prostate cancer. J Urol, 157 : 439-444, 1997
PubMed
10) Peris P, et al : Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin Rheumatol, 26 : 958-961, 2007
PubMed
11) Zmuda JM, et al : Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men. J Bone Miner Res, 15 : 1417-1424, 2000
 
12) 岡田正人 : 第11回 非専門医のためのアレルギーリウマチ診療Update, 日経メディカル, 2011
 
Weinstein RS : Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med, 365 : 62-70, 2011
PubMed
P.275 掲載の参考文献
1) Bernardy K, et al : Cognitive behavioural therapies for fibromyalgia. Cochrane Database of Systematic Reviews 2013
PubMed
Karjalainen KA, et al : Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database of Systematic Reviews 2000
 
Wiffen PJ, et al : Antiepileptic drugs for neuropathic pain and-fibromyalgia-an overview of Cochrane reviews. Cochrane Database Syst Rev, 11 : 11, 2013
PubMed
Goldenberg DL et al : Management of fibromyalgia syndrome. JAMA, 292 : 2388-2395, 2004
PubMed
Arnold LM et al : Gabapentin in the treatment of fibromyaglia : a randomized, double-blind, placebocontrolled, multicenter trial. Arthritis Rheum, 56 : 1336-1344, 2007
 
Carville SF, et al : EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis, 67 : 536-541, 2008
PubMed
Ferrari R, et al : A questionnaire using the modified 2010 American College of Rheumatology criteria for fibromyalgia : specificity and sensitivity in clinical practice. J Rheumatol, 40（9）: 1590-1595, 2013
 
P.283 掲載の参考文献
1) Bohan A, Peter JB : Polymyositis and dermatomyositis. NEJM, 292 : 344-347, 403-407, 1975
 
2) 三森経世, 他 : 多発性筋炎・皮膚筋炎における自己抗体研究の進歩 : 筋炎合併間質性肺炎のバイオマーカー. 日本内科学会雑誌, 101 : 488-494, 2012
 
3) Lazarou IN, et al : Classification, diagnosis, and management of idiopathic inflammatory myopathies. J Rheumatol, 40 : 550-564, 2013
PubMed
Marinos CD, Reinhard H. : Polymyositis and dermatomyositis. Lancet, 362 : 971-982, 2003
 
P.287 掲載の参考文献
1) Scully C : Clinical practice. Aphthous ulceration. N Engl J Med, 355 : 165-172, 2006
PubMed
2) Flynn TR, et al : Case records of the Massachusetts general hospital. Case 6-2010. A 37-year-old man with a lesion on the tongue. N Engl J Med, 362 : 740-748, 2010
 
3) Weathers DR, Griffin JW : Intraoral ulcerations of recurrent herpes simplex and recurrent aphthae : two distinct clinical entities. J Am Dent Assoc, 81 : 81-87, 1970
PubMed
Rogers RS 3rd : Recurrent aphthous stomatitis in the diagnosis of Behcet's disease. Yonsei Med J, 38 : 370-379, 1997
PubMed
Ideguchi H, et al : Behcet disease : evolution of clinical manifestations. Medicine (Baltimore), 90 : 125-132, 2011
PubMed

第6章 救急編 急性単関節炎のアプローチ

P.293 掲載の参考文献
1) Guideline for the initial evaluation of the adult patients with acute musculoskeltal symptoms. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum, 39 : 1-9, 1996
 
2) Klippel JH : Primer on the rheumatic disease 12th ed. p142, Arthritis foundation, 2001
 
「筋骨格注射スキル」 (岸本暢将 監訳), 羊土社, 2008
 
P.297 掲載の参考文献
1) Harris E, et al : Kelly's Textbook of Rheumatology, W B Saunders Co, p1621, table98-2, 2004
 
2) Geirsson AJ, et al : Septic arthritis in Iceland 1990-2002 : increasing incidence due to iatrogenic infections. Ann Rheum Dis, 67 : 638-643, 2008
PubMed
3) Margaretten ME, et al : Does this adult patient have septic arthritis? JAMA, 197 : 1478-1488, 2007
 
Kaandorp CJ, et al : The outcome of bacterial arthritis : a prospective community-based study. Arthritis Rheum, 40 : 884-892, 1997
PubMed
P.302 掲載の参考文献
1) 宇都宮雅子 : 痛風/偽痛風/化膿性関節炎. Hospitalist, 2-2，p500，図5, メディカル・サイエンス・インターナショナル, 2014
 
Zhang W, Doherty M, Bardin T, et al : European league against rheumatism recommendations for calcium pyrophosphate deposition. part I : terminology and diagnosis. Ann Rheum Dis, 70 : 563-570, 2011
PubMed
Zhang W, Doherty M, Pascual E, et al : EULAR recommendations for calcium pyrophosphate deposition. part II : Management. Ann Rheum Dis, 70 : 571-575, 2011
PubMed
P.308 掲載の参考文献
1) 「高尿酸血症・痛風の治療ガイドライン」第2版 (日本痛風・核酸代謝学会), 2010
 
2) Zhang W, et al : EULAR evidence based recommendations for gout. part I : diagnosis. report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis, 65 : 1301-1311, 2006
PubMed
3) Zhang W, et al : EULAR evidence based recommendations for gout. part II : management. report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis, 65 : 1312-1324, 2006
PubMed
4) Janssens H J, et al : Use of oral prednisolone or naproxen for the treatment of gout arthritis : a double-blind, randomised equivalence trial. Lancet, 371 : 1854-1860, 2008
 
Khanna D, et al : 2012 American College of Rheumatology guidelines for management of gout. Part 1 : Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res, 64 : 1431-1446, 2012
PubMed
Khanna D, et al : 2012 American College of Rheumatology guidelines for management of gout. Part 2 : Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res, 64 : 1447-1461, 2012
PubMed

第7章 リウマチ治療薬

P.318 掲載の参考文献
1) Huscher D, et al : Dose-related pattern of glucocorticoid-induced side effects. Ann Rheum Dis, 68 : 1119-1124, 2009
PubMed
2) Grossman JM, et al : American college of rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res, 62 : 1515-1526, 2010
PubMed
3) Suzuki Y, et al : Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese society for bone and mineral research : update. J Bone Miner Metab, 32 : DOI 10 1007/s00774-014-0586-0586 (和文概略版), 2014
 
4) Buttgereit F, et al : Glucocorticoids in the treatment of rheumatic diseases : an update on the mechanisms of action. Arthritis & Rheumatism, 50 : 3408-3417, 2004
PubMed
5) Hoes JN, et al : EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis, 66 : 1560-1567, 2007
PubMed
6) Duru N, et al : EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis, 72 : 1905-1913, 2013
PubMed
P.327 掲載の参考文献
1) McInnes IB, Schett G : The pathogenesis of rheumatoid arthritis. N Engl J Med, 365 : 2205-2219, 2011
PubMed
2) Nam JL, et al : Efficacy of biological disease-modifying antirheumatic drugs : a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis, 73 : 516-528, 2014
PubMed
3) 「日本リウマチ学会ガイドライン (2014年6月29日改訂版) 」日本リウマチ学会ホームページ 医薬・医療情報 http://www.ryumachi-jp.com/guideline.html http://www.ryumachi-jp.com/iyaku.html
 
4) Ramiro S, et al : Safety of synthetic and biological DMARDs : a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis, 73 : 529-535, 2014
PubMed
5) 日本肝臓学会肝炎診療ガイドライン作成委員会, 「B型肝炎治療ガイドライン (第2版)」, 2014年6月 http://www.jsh.or.jp/medical/guidelines/jsh_guidlines/hepatitis_b
 
6) 日本リウマチ学会「B型肝炎ウイルス感染リウマチ性疾患患者への免疫抑制療法に関する提言」 (2011年10月17日改訂) http://www.ryumachi-jp.com/info/news140423.pdf
 
7) 「エキスパートナースに聞くレミケード投与の実際」 (2014年11月), 田辺三菱製薬
 
8) 「ヴェゲナ肉芽腫症・顕微鏡的多発血管炎 リツキサン注使用ガイド」 (2014年11月), 中外製薬
 
米国リウマチ学会ホームページ Drug Safety Quarterly http://www.rheumatology.org/Content.aspx?id=19430
 

書評

最近チェックした商品履歴

Loading...